COVID-19, Australia: Epidemiology Report 20: Fortnightly reporting period ending 5 July 2020
Notified cases of COVID-19 and associated deaths reported to the National Notifiable Diseases Surveillance System (NNDSS) to 5 July 2020
DOI:
https://doi.org/10.33321/cdi.2020.44.63Keywords:
SARS-CoV-2, novel coronavirus, 2019-nCoV, coronavirus disease 2019, COVID-19, acute respiratory disease, epidemiology, AustraliaAbstract
Over the past fortnightly reporting period (22 June to 5 July):
• The national incidence of COVID-19 remained low, with very few cases reported by most jurisdictions in this reporting period.
• The majority of the current cases reported over this fortnight are from Victoria, with an increasing number and proportion of cases reported as being locally acquired.
• Total case numbers have increased with an average of 54 cases reported on any one day, more than twice the average number reported in the previous reporting period.
• The number and proportion of deaths associated with COVID-19 remains low and it appears that vulnerable populations have not been disproportionately affected by COVID-19 overall.
• Testing rates continue to be high across all jurisdictions, with the nationwide positivity rate remaining very low at less than 0.3%.
In this reporting period, the number of cases reported nationally has increased from 214 (8 June to 21 June) to 897 (22 June to 5 July). Of the cases notified in this reporting period, 87% (781 cases) were notified from Victoria and 89% of these cases were acquired locally. Of the remaining 116 cases reported from other jurisdictions only 6% were locally acquired. The increase in Victoria is attributable to multiple epidemiologically linked outbreaks across a range of settings and locations.
Downloads
References
Australian Government Department of Health. Australian Health Protection Principal Committee (AHPPC) statement on recent outbreaks of COVID-19 in Victoria. [Internet.] Canberra: Australian Government Department of Health; 21 June 2020. [Accessed on 24 June 2020.] Available from: https://www.health.gov.au/news/australian-health-protection-principal-committee-ahppc-statement-on-recent-outbreaks-of-covid-19-in-victoria.
Public Health Agency of Canada (PHAC). Coronavirus disease 2019 (COVID-19). Epidemiology update. Updated: July 8, 2020, 7 pm EDT. [Internet.] Ottawa: Government of Canada, PHAC; 2020. [Accessed on 9 July 2020.] Available from: https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid-19-cases.html.
European Centre for Disease Prevention and Control (ECDC). COVID-19 surveillance report: Week 26, 2020. [Internet.] Solna: ECDC; 4 July 2020. [Accessed on 9 July 2020.] Available from: https://covid19-surveillance-report.ecdc.europa.eu/.
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020. doi: https://doi.org/10.1016/j.jinf.2020.04.021.
Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775-1776. doi: https://doi.org/10.1001/jama.2020.4683.
Statistics Canada. Table 13-10-0775-01. Detailed preliminary information on cases of COVID-19: 6 Dimensions (Aggregated data), Public Health Agency of Canada. [Internet.] Ottawa: Statistics Canada; 2020. [Accessed on 10 July 2020.] Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310077401.
Monash Health. FluCAN (Influenza surveillance): FluCAN (The Influenza Complications Alert Network) [Internet.] Melbourne: Monash Health; 2020. Available from: https://monashhealth.org/services/monash-infectious-diseases/research/influenza-research/flucan-influenza-surveillance-2/.
COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: Epidemiology Report 16: Reporting week ending 23:59 AEST 17 May 2020. Commun Dis Intell (2018). 2020;44. doi: https://doi.org/10.33321/cdi.2020.44.45.
Australian and New Zealand Intensive Care Society (ANZICS). SPRINT-SARI: Short period incidence study of severe acute respiratory infection. [Internet.] Camberwell: ANZICS; 19 March 2020. [Accessed on 9 July 2020.] Available from: https://www.anzics.com.au/current-active-endorsed-research/sprint-sari/.
Centers for Disease Control and Prevention (CDC). COVID-Net: a weekly summary of U.S. COVID-19 hospitalization data. COVID-19 laboratory-confirmed hospitalizations: preliminary data as of May 23, 2020. [Internet.] Atlanta: United States Government Department of Health and Human Services, CDC; 2020. [Accessed on 3 June 2020.] Available from: https://gis.cdc.gov/grasp/COVIDNet/COVID19_5.html.
ECDC. COVID-19 surveillance report: Week 2020-19. 6: Other epidemiological characteristics. [Internet.] Solna: ECDC; 14 May 2020. [Accessed on 19 May 2020.] Available from: https://covid19-surveillance-report.ecdc.europa.eu/#6_other_epidemiological_characteristics.
Government of Canada. Epidemiological summary of COVID-19 cases in Canada: last data update May 19, 2020, 11:00 ET. [Internet.] Ottawa: Government of Canada; 2020. [Accessed on 19 May 2020.] Available from: https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid-19-cases.html.
Australian Government Department of Health. Coronavirus (COVID-19) advice for the health and aged care sector. [Internet.] Canberra: Australian Government Department of Health; 2020. [Accessed 3 June 2020.] Available from: https://www.health.gov.au/news/health-alerts/novel-coronavirus-2019-ncov-health-alert/coronavirus-covid-19-advice-for-the-health-and-aged-care-sector.
Communicable Diseases Network Australia (CDNA). Coronavirus disease 2019 (COVID-19) outbreaks in residential care facilities: CDNA national guidelines for the prevention, control and public health management of COVID-19 outbreaks in residential care facilities in Australia. Canberra: Australian Government Department of Health, CDNA; 13 March 2020. [Accessed on 3 June 2020.] Available from: https://www.health.gov.au/sites/default/files/documents/2020/03/coronavirus-covid-19-guidelines-for-outbreaks-in-residential-care-facilities.pdf.
Government of New South Wales. What you can and can’t do under the rules: visiting family and friends at home. [Internet.] Sydney: Government of New South Wales; 2020. [Accessed on 7 July 2020.] Available from: https://www.nsw.gov.au/covid-19/what-you-can-and-cant-do-under-rules#visiting-family-and-friends-at-home.
Government of New South Wales: NSW Health. Stay COVID-19 safe as restrictions eased. [Internet.] Sydney: Government of New South Wales, Minister for Health; 1 July 2020. [Accessed on 7 July 2020.] Available from: https://www.nsw.gov.au/covid-19/latest-news-and-updates.
Department of Health and Human Services (DHHS). Victoria’s restriction levels. [Internet.] Melbourne: Victoria State Government, DHHS; 2020. [Accessed on 7 July 2020.] Available from: https://www.dhhs.vic.gov.au/victorias-restriction-levels-covid-19.
Queensland Government. Roadmap to easing restrictions. [Internet.] Brisbane: Queensland Government; 2020. [Accessed on 7 July 2020.] Available from: https://www.covid19.qld.gov.au/government-actions/roadmap-to-easing-queenslands-restrictions.
Government of Western Australia. COVID-19 coronavirus: WA Roadmap. Phase 4. [Internet.] Perth: Government of Western Australia; 2020. [Accessed on 23 June 2020.] Available from: https://www.wa.gov.au/organisation/department-of-the-premier-and-cabinet/covid-19-coronavirus-wa-roadmap#phase4.
Government of South Australia. Recovery from COVID-19. [Internet.] Adelaide: Government of South Australia; 2020. [Accessed on 22 June 2020.] Available from: https://www.covid-19.sa.gov.au/recovery.
Government of South Australia. South Australian roadmap for easing COVID-19 restrictions. Adelaide: Government of South Australia; 2020. [Accessed on 22 June 2020.] Available from: https://www.covid-19.sa.gov.au/__data/assets/pdf_file/0012/195879/200059.4-COVID-19-RoadMap-19June-V7.pdf.
Tasmanian Government. Roadmap to recovery. [Internet.] Hobart: Tasmanian Government; 2020. [Accessed on 7 July 2020.] Available from: https://coronavirus.tas.gov.au/families-community/roadmap-to-recovery.
Australian Capital Territory Government. Canberra’s recovery plan: COVID-19 easing of restrictions roadmap as at 12 June 2020. Canberra: Australian Capital Territory Government; 2020. [Accessed on 7 July 2020.] https://www.covid19.act.gov.au/__data/assets/pdf_file/0009/1558701/COVID-19-Easing-of-Restrictions-Roadmap-Release-2.0-12-June-2020.pdf.
Northern Territory Government. Roadmap to the new normal. Stage 3 – Friday 5 June (current). [Internet.] Darwin: Northern Territory Government; 2020. [Accessed on 22 June 2020.] Available from: https://coronavirus.nt.gov.au/roadmap-new-normal#/stage_3_friday_5_june_current.
World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) situation report – 167. [Internet.] Geneva: WHO; 2020. [Accessed on 6 July 2020.] Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200705-covid-19-sitrep-167.pdf.
WHO. WHO Coronavirus Disease (COVID-19) dashboard. [Internet.] Geneva: WHO; 5 July 2020. [Accessed on 6 July 2020.] Available from: https://covid19.who.int/.
Liu C, Zhao Y. Beijing reports single-digit cases for 8 consecutive days, eyes zero this week. [Internet.] Beijing: Global Times; 6 July 2020. [Accessed on 6 July 2020.] Available from: https://www.globaltimes.cn/content/1193614.shtml.
Singapore Government Ministry of Health. 5 July 2020 Daily Report on COVID-19. Singapore Government Ministry of Health; 2020. [Accessed on 6 July 2020.] Available from: https://www.moh.gov.sg/docs/librariesprovider5/local-situation-report/situation-report---5-jul-2020.pdf.
Kim CR. Office cluster pushes Tokyo coronavirus cases to one-and-half-month high, governor says. [Internet.] London: Reuters; 24 June 2020. [Accessed on 6 July 2020.] Available from: https://www.reuters.com/article/us-health-coronavirus-japan/office-cluster-pushes-tokyo-coronavirus-cases-to-one-and-half-month-high-governor-says-idUSKBN23V0I9.
Ministry of Health and Welfare. Situation report 4 July 2020. Sejong: Republic of Korea, Ministry of Health and Welfare; 2020. [Accessed on 6 July 2020.] Available from: http://ncov.mohw.go.kr/upload/viewer/skin/doc.html?fn=1593762642540_20200703165042.pdf&rs=/upload/viewer/result/202007/.
Roser M, Ritchie H, Ortiz-Ospina E, Hasell J. Statistics and research: Coronavirus pandemic (COVID-19). [Website.] Oxford: Our World in Data; 2020. [Accessed on 7 July 2020.] https://ourworldindata.org/coronavirus.
WHO. COVID-19: 29 June 2020. Morbidity and Mortality Weekly Update (MMWU) #18. Bangladesh: WHO; 2020. [Accessed on 7 July 2020.] Available from: https://www.who.int/docs/default-source/searo/bangladesh/covid-19-who-bangladesh-situation-reports/who-covid-19-update-18-20200629.pdf.
WHO. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). [Internet.] Geneva: WHO; 2020. [Accessed 1 Mar 2020.] Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.
Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020. doi: https://doi.org/10.1038/s41586-020-2196-x.
Cheng HY, Jian SW, Liu DP, Ng TC, Huang WT, Lin HH. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. 2020. doi: https://doi.org/10.1001/jamainternmed.2020.2020.
Korea Centers for Disease Control and Prevention (KCDC). Division of risk assessment and international cooperation. Findings from investigation and analysis of re-positive cases. [Internet.] Cheongju: Government of South Korea, KCDC; 2020. [Accessed on 24 May 2020.] Available from: https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030&act=view&list_no=367267&nPage=1.
Zhu Y, Bloxham CJ, Hulme KD, Sinclair JE, Tong ZW, Steele LE et al. Children are unlikely to have been the primary source of household SARS-CoV-2 infections. medRxiv. 2020. doi: https://doi.org/10.1101/2020.03.26.20044826.
Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT, Melsted P, Norddahl GL et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med. 2020. doi: https://doi.org/10.1056/NEJMoa2006100.
ECDC. Rapid risk assessment: Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children – 15 May 2020. Solna: ECDC; 2020. [Accessed on 19 May 2020.] Available from: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-risk-assessment-paediatric-inflammatory-multisystem-syndrome-15-May-2020.pdf.
WHO. Coronavirus disease 2019 (COVID-19) situation report – 29. [Internet.] Geneva: WHO; 2020. [Accessed 22 Feb 2020.] Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200218-sitrep-29-covid-19.pdf.
Pung R, Chiew CJ, Young BE, Chin S, Chen M, Clapham HE. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet. 2020;395(10229):1039–46.
Rockett RJ, Arnott A, Lam C, Sadsad R, Timms V, Gray KA et al. Revealing COVID-19 transmission by SARS-CoV-2 genome sequencing and agent based modelling. bioRxiv. doi: https://doi.org/10.1101/2020.04.19.048751.
Nextstrain team. Genomic epidemiology of novel coronavirus – Oceania-focused subsampling. [Internet.] [Accessed on 5 May 2020.] Available online: https://nextstrain.org/ncov/oceania?c=division&f_country=Australia&l=radial.
Seemann T, Lane C, Sherry N, Duchene S, Goncalves da Silva A, Caly L et al. Tracking the COVID-19 pandemic in Australia using genomics. medRxiv. 2020 doi: https://doi.org/10.1101/2020.05.12.20099929.
Sun P, Qiu S, Liu Z, Ren J, Xi JJ. Clinical characteristics of 50466 patients with 2019-nCoV infection. medRxiv. 2020. doi: https://doi.org/10.1101/2020.02.18.20024539.
Li B, Bai W, Hashikawa T. The neuroinvasive potential of SARS-CoV-2 may be at least partially responsible for the respiratory failure of COVID-19 patients. J Med Virol. 2020. doi: https://doi.org/10.1002/jmv.25728.
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurological manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;e201127. doi: https://doi.org/10.1001/jamaneurol.2020.1127.
Drew DA, Nguyen LH, Steves CJ, Wolf J, Spector TC, Chan AT. Rapid implementation of mobile technology for real-time epidemiology of COVID-19. medRxiv. 2020. doi: https://doi.org/10.1101/2020.04.02.20051334.
Venkatakrishnan AJ, Puranik A, Anand A, Zemmour D, Yao X, Wu X et al. Knowledge synthesis from 100 million biomedical documents augments the deep expression profiling of coronavirus receptors. bioRxiv. 2020. doi: https://doi.org/10.1101/2020.03.24.005702.
Brann DH, Tsukahara T, Weinreb C, Logan DW, Datta SR. Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients. bioRxiv. 2020. doi: https://doi.org/10.1101/2020.03.25.009084.
Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. doi: https://doi.org/10.1001/jamacardio.2020.1096.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. doi: https://doi.org/10.1001/jamacardio.2020.1017.
Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020. doi: https://doi.org/10.1001/jamacardio.2020.1286.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020. doi: https://doi.org/10.1016/S0140-6736(20)31094-1.
Morand A, Urbina D, Fabre A. COVID-19 and Kawasaki like disease: the known-known, the unknown-known and the unknown-unknown. Preprints. 2020;2020050160. doi: https://doi.org/10.20944/preprints202005.0160.v1.
WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. [Internet.] Geneva: WHO; 2020. [Accessed 23 Feb 2020.] Available from: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.
Harrison C. Coronavirus puts drug re-purposing on the fast track. Nat Biotechnol. 2020. doi: https://doi.org/10.1038/d41587-020-00003-1.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research. 2020;30;269–71.
Tang W, Cao Z, Han M, Wang Z, Chen W, Sun W et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ. 2020. doi: https://doi.org/10.1136/bmj.m1849.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G et al. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382:1787–99.
National Institute of Allergy and Infectious Diseases (NIAID). NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19. [Internet.] Bethesda: Government of the United States of America, National Institutes of Heath, NIAID; 2020. [Accessed on 19 May 2020.] Available from: https://www.niaid.nih.gov/news-events/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19.
Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395(10236);1569–78.
University of Oxford. Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19. [News release.] Oxford: University of Oxford; 16 June 2020. [Accessed on 24 June 2020.] Available from: https://www.recoverytrial.net/files/recovery_dexamethasone_statement_160620_final.pdf.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
